We found that Acer3 mRNA level and its enzymatic activity were not changed in liver tissues from NAFL mice, but were significantly upregulated in liver tissues from NASH mice (Fig. 1d, e). This evidence concerns the gene ACER3 and metabolic dysfunction-associated steatohepatitis.